Legal & General Group
TLSI icon

Legal & General Group’s TriSalus Life Sciences TLSI Stock Holding History

Legal & General Group’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Buy
4,666
+1,933
+71% +$7.68K ﹤0.01% 3089
2026
Q1 		$10.9K Sell
2,733
-137
-5% -$671 ﹤0.01% 3159
2025
Q4 		$20K Buy
2,870
+1,416
+97% +$7.93K ﹤0.01% 3030
2025
Q3 		$6.76K Hold
1,454
– – ﹤0.01% 3344
2025
Q2 		$7.92K Buy
+1,454
New +$7.8K ﹤0.01% 3341

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Legal & General Group's TLSI Position: Q2 2026 in Review

Legal & General Group increased its TriSalus Life Sciences (TLSI) stake by 71% in Q2 2026, buying an estimated $7.68K and bringing the position to 4,666 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3089.

Legal & General Group first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Legal & General Group held 4,666 shares of TriSalus Life Sciences worth $21.2K as of Q2 2026.
  • Legal & General Group bought 1,933 TriSalus Life Sciences shares in Q2 2026, an estimated $7.68K.
  • TriSalus Life Sciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3089 holding.
  • Legal & General Group first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.